The move aims to leverage the company’s products “into the pain care marketplace and offer patients and doctors more solutions to helping them treat chronic back pain,” President and CEO Trent Northcutt said in a Nov. 30 news release.
Aurora Spine’s pain portfolio includes the Zip screwless fusion procedure and the Silo posterior si-fusion system.
The global pain management devices market is projected to hit $14.6 billion by 2026, increasing at a compound annual growth rate of 13.8 percent, according to Research And Markets.
More articles on devices:
Dr. Daniel Lieberman: How hospitals will react to outpatient migration and what’s next for spine surgery at ASCs
Illinois Bone & Joint Institute CEO on M&As in 2020 and future strategy
Nick Saban lauds orthopedic surgeon named as SEC Team Physician of the Year
